This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
GLP-1
Our depth — beyond the mirror
Deeper analysis, verdict reasoning, and per-archetype recommendations from our research team.
▸ Editor's verdict OTHER HIGH
"GLP-1 is a class label, not a single compound. See individual member pages: semaglutide (Ozempic/Wegovy/Rybelsus, weekly), tirzepatide (Mounjaro/Zepbound — dual GLP-1/GIP, weekly), liraglutide (Saxenda/Victoza, daily), and retatrutide (investigational triple GIP/GLP-1/GCG agonist). For this archetype (lean 20yo MMA athlete), GLP-1 agonists are not indicated — no obesity/T2DM, muscle preservation concerns, performance/appetite drawbacks. This page exists for context and search."
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.